NeuBase Therapeutics Inc (NBSE)
0.378
0.00 (0.00%)
USD |
NASDAQ |
May 14, 16:00
NeuBase Therapeutics Cash and Short Term Investments (Quarterly): 12.57M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 12.57M |
| June 30, 2023 | 14.75M |
| March 31, 2023 | 13.84M |
| December 31, 2022 | 17.39M |
| September 30, 2022 | 23.15M |
| June 30, 2022 | 29.85M |
| March 31, 2022 | 38.96M |
| December 31, 2021 | 47.33M |
| September 30, 2021 | 52.89M |
| June 30, 2021 | 58.84M |
| March 31, 2021 | 24.25M |
| December 31, 2020 | 27.98M |
| September 30, 2020 | 31.99M |
| June 30, 2020 | 35.92M |
| March 31, 2020 | 5.772M |
| December 31, 2019 | 7.731M |
| September 30, 2019 | 10.31M |
| June 30, 2019 | 1.425M |
| March 31, 2019 | 2.129M |
| December 31, 2018 | 3.110M |
| September 30, 2018 | 0.2496M |
| June 30, 2018 | 4.435M |
| March 31, 2018 | 5.215M |
| December 31, 2017 | 8.724M |
| September 30, 2017 | 12.80M |
| Date | Value |
|---|---|
| June 30, 2017 | 18.08M |
| March 31, 2017 | 9.521M |
| December 31, 2016 | 13.49M |
| September 30, 2016 | 12.55M |
| June 30, 2016 | 17.62M |
| March 31, 2016 | 21.88M |
| December 31, 2015 | 25.33M |
| September 30, 2015 | 28.70M |
| June 30, 2015 | 30.98M |
| March 31, 2015 | 32.82M |
| December 31, 2014 | 10.44M |
| September 30, 2014 | 13.22M |
| June 30, 2014 | 14.88M |
| March 31, 2014 | 3.474M |
| December 31, 2013 | 4.016M |
| September 30, 2013 | 5.123M |
| June 30, 2013 | 6.049M |
| March 31, 2013 | 1.765M |
| December 31, 2012 | 2.069M |
| September 30, 2012 | 2.632M |
| June 30, 2012 | 1.445M |
| March 31, 2012 | 0.7753M |
| December 31, 2011 | 1.262M |
| September 30, 2011 | 0.4698M |
| June 30, 2011 | 0.8785M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.425M
Minimum
Jun 2019
58.84M
Maximum
Jun 2021
25.28M
Average
23.70M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | 4.089M |
| Stoke Therapeutics Inc | 178.58M |
| ABVC BioPharma Inc | 0.1395M |
| MAIA Biotechnology Inc | 7.151M |
| Aprea Therapeutics Inc | 21.61M |